A Combined Analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council Randomized Clinical Trials for the Prophylactic Treatment of Stage TaT1 Bladder Cancer
- 1 December 1996
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- p. 1934-1940
- https://doi.org/10.1097/00005392-199612000-00010
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- A Low Dose Bacillus Calmette-Guerin Regimen in Superficial Bladder Cancer Therapy: Is it Effective?Journal of Urology, 1991
- The effect of Intravesical Instillations of Thiotepa, Mitomycin C, and Adriamycin on Normal Urothelium: An Experimental Study in RatsJournal of Urology, 1991
- Cancer in the European community and its member statesEuropean Journal of Cancer and Clinical Oncology, 1990
- Secondary hematologic neoplasm after intravesical chemotherapy for superficial bladder carcinomaCancer, 1990
- Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)BMJ, 1988
- Bacillus Calmette-Guerin for Treatment of Superficial Transitional Cell Carcinoma of the Bladder in Patients who have failed Thiotepa and/or Mitomycin CJournal of Urology, 1987
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Does Intravesical Chemotherapy Prevent Invasive Bladder Cancer?Journal of Urology, 1984
- The Effect of Mitomycin C on Superficial Bladder CancerJournal of Urology, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958